Senior insider sale
President & CEO at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$10.27M
62.25K shares
What this filing means
HASSANEIN WALEED H plans to sell 62.25K shares of TRANSMEDICS GROUP, INC. valued at approximately $10.27M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2024ACC: 0001972362-24-001206
DirectorOfficer· President & CEO
Since May 2019
62.25K
Shares to sell
$10.27M
Approx. market value
45K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
8/21/2024
45KTotal acquired45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2024 | STOCK OPTION EXERCISE COMPENSATION | 45K | — |
| Total | 45K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
17.25K
Market value
$2.48M
8/15/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
45K
Market value
$7.79M
8/21/2024
Total
Units
62.25K
Value
$10.27M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/15/2024 | 17.25K | $2.48M | — | Completed |
| Planned — Approximate Date | ||||
8/21/2024 | 45K | $7.79M | NASDAQ | Planned |
| Total | 62.25K | $10.27M | ||